Wall Street Worries FDA Cuts Will Slow Drug Approvals
Steep cuts at the Food and Drug Administration might slow down drug approvals vital to the biopharma industry.
Novo Nordisk to license obesity drug from Lexicon in up to $1 billion deal
Novo Nordisk is licensing Lexicon Pharmaceuticals' experimental obesity drug in a deal worth up to $1 billion, the Danish ...
Top vaccine official at FDA resigns citing RFK Jr., ‘misinformation’
A top vaccine official at the Food and Drug Administration (FDA) resigned, citing Health and Human Services (HHS) Secretary ...